You just read:

ARMGO Pharma Receives $1 Million Award from MDA to Support Advancement of Rycal Compound ARM210 as a Novel Treatment for Duchenne Muscular Dystrophy

News provided by

ARMGO Pharma; Muscular Dystrophy Association

Apr 17, 2013, 06:00 ET